Use of novel pan-CDK inhibitors for treating tumors

Details for Australian Patent Application No. 2011234654 (hide)

Owner Bayer Intellectual Property GmbH

Inventors Lucking, Ulrich; Siemeister, Gerhard; Wengner, Antje Margret

Agent Davies Collison Cave

Pub. Number AU-A-2011234654

PCT Pub. Number WO2011/120922

Priority 10 2010 014 426.6 01.04.10 DE

Filing date 28 March 2011

Wipo publication date 6 October 2011

International Classifications

A61K 31/505 - Pyrimidines

A61P 35/00 Antineoplastic agents

A61P 35/02 Antineoplastic agents

Event Publications

25 October 2012 PCT application entered the National Phase

  PCT publication WO2011/120922 Priority application(s): WO2011/120922

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011234656-Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant

2011234646-Method for measurement of calcium ions